Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:01 PM
Study NCT ID:
NCT01498458
Status:
COMPLETED
Last Update Posted:
2022-06-10
First Post:
2011-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Sponsor:
GBG Forschungs GmbH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GBG 62
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None